Component portfolio and prices
On this page:
- Bar codes for updating LIMS for apheresis platelets in platelet additive solution (PAS) and plasma
- Component portfolio
- Component and transport prices
- Non stock and special components, including components for urgent requests
Component portfolio
Portfolio of blood components and guidance for their clinical use (PDF 1MB)
This provides details of therapeutic blood components including constituents, and information on:
- specifications
- identification barcodes
- quality standards and monitoring
- storage and handling
- clinical indications and contraindications
- specialist requirements
- dosage, administration, recognition of adverse effects
- material safety data sheet
Apheresis platelets in PAS and plasma
We started issuing apheresis platelets in platelet additive solution (PAS) and plasma on12 January 2026, alongside the existing apheresis platelets in plasma. You may receive either component after 12 January. Use these identification bar codes (PDF 29KB) to update your LIMS.
Please refer to our FAQs (PDF 484KB) for more information.
Neonatal apheresis platelets in PAS and plasma
In June 2026 we will start issuing apheresis platelets in PAS and plasma for neonates. You may receive the current component or the new component when we implement the change. Please use the identification bar codes, version 2 (PDF 163KB) to update your LIMS. Version 2 (22 May 2026) has the correct bar code for the component for pack 8 with the Pulse code 0P18.
If you have any questions email michelle.ray@nhsbt.nhs.uk. Michelle is the Projects and Operational Support Lead in the Technical and Scientific Development team.
Component and transport prices
Non stock and special components, including components for urgent requests
It is important you allow for processing and transport time when ordering these components. Please refer to Appendix 7 in the portfolio of blood components (download the PDF file of the portfolio using the link at the top of this page).